Novacyt S.A. (CDI) (NCYT)

Sector:

Health Care

Index:

FTSE AIM All-Share

39.45p
   
  • Change Today:
    -0.65p
  • 52 Week High: 118.00
  • 52 Week Low: 38.00
  • Currency: UK Pounds
  • Shares Issued: 70.63m
  • Volume: 38,638
  • Market Cap: £27.86m
  • RiskGrade: 453
  • Beta: 0.00

NCYT Overview

The Novacyt Group is a rapidly growing, international diagnostics group with a growing portfolio of cancer and infectious disease products and services. Through its proprietary technology platform, NOVAPrep®, and molecular platform, genesig®, Novacyt is able to provide an extensive range of oncology and infectious disease diagnostic products across an extensive international distributor network. The Group has diversified sales from diagnostic reagents used in oncology, microbiology, haematology and serology markets, and its global customers and partners include major corporates.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -254.9% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 2.4 n/a
Pr/Book 0.3  
Latest F'cast
Revenue -45.0% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

NCYT Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 11.47 (3.43) (8.00)p n/a n/a n/a n/a 0.0%
31-Dec-20 277.20 165.17 194.00p 4.4 n/a n/a n/a 0.0%
31-Dec-21 92.60 (5.66) (9.00)p n/a n/a n/a n/a 0.0%
31-Dec-22 21.04 (20.05) (31.00)p n/a n/a n/a n/a 0.0%
31-Dec-23 11.58 (28.57) (39.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

NCYT Company Announcements

Notice of Results 22-Apr-2025 07:00 RNS
Liquidity Agreement and Total Voting Rights 01-Apr-2025 11:45 RNS
Update re. Lab 21 HSE Prosecution 18-Mar-2025 16:15 RNS

Latest NCYT Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

NCYT Market Data

Currency UK Pounds
Share Price 39.45p
Change Today -0.65p
% Change -1.62 %
52 Week High 118.00
52 Week Low 38.00
Volume 38,638
Shares Issued 70.63m
Market Cap £27.86m
Beta 0.00
RiskGrade 453

NCYT Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
74.89% above the market average74.89% above the market average74.89% above the market average74.89% above the market average74.89% above the market average
81.82% above the sector average81.82% above the sector average81.82% above the sector average81.82% above the sector average81.82% above the sector average
Price Trend
61.77% below the market average61.77% below the market average61.77% below the market average61.77% below the market average61.77% below the market average
40.54% below the sector average40.54% below the sector average40.54% below the sector average40.54% below the sector average40.54% below the sector average
Income Not Available
Growth
66.3% below the market average66.3% below the market average66.3% below the market average66.3% below the market average66.3% below the market average
94.12% below the sector average94.12% below the sector average94.12% below the sector average94.12% below the sector average94.12% below the sector average

NCYT Dividends

No dividends found

Trades for 25-Apr-2025

Time Volume / Share Price
15:56 1,043 @ 38.29p
13:07 1,589 @ 39.45p
12:09 10,000 @ 39.83p
12:02 300 @ 39.45p
12:00 10,000 @ 39.50p

NCYT Key Personnel

CFO Steve Gibson

Top of Page